Loading patent…
AssigneesLactomason Co., Ltd., Korea Research Institute of Bioscience and Biotechnology
InventorsEun Ju PARK, Yun Jung LEE, Hee Soo JEONG, Minn SOHN, Hyeon Tak HAN, So Lim SHIN, Doo-Sang PARK
Estimating the term…
A method according to the present disclosure improves sleep states, maintains a sound sleep, restores the balance of gut microbiota disrupted by sleep disorders, and supports the management of health including metabolic syndrome. Under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, the Limosilactobacillus reuteri LM1063 strain was deposited with the international depositary authority: the Korean Collection for Type Cultures on Mar. 23, 2017, under the Accession Number: KCTC 13232BP.
A method of improving sleep, comprising administering an amount of a pharmaceutical composition to a subject in need thereof, wherein the pharmaceutical composition comprises one or more of a Limosilactobacillus reuteri strain LM1063 (KCTC13232BP), a culture of the strain, fragments of the strain, and extracts of the strain as an active ingredient.
A method of improving sleep, comprising administering an amount of a health functional food to a subject in need thereof, wherein the health functional food comprises one or more of a Limosilactobacillus reuteri strain LM1063 (KCTC13232BP), a culture of the strain, fragments of the strain, and extracts of the strain as an active ingredient.
A method of improving sleep, comprising administering an amount of a food material to a subject in need thereof, wherein the food material comprises one or more of a Limosilactobacillus reuteri strain LM1063 (KCTC13232BP), a culture of the strain, fragments of the strain, and extracts of the strain as an active ingredient.
Dependencies are inferred from the claim text.